Page last updated: 2024-10-29

staurosporine aglycone and Brain Disorders

staurosporine aglycone has been researched along with Brain Disorders in 1 studies

staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor

Research Excerpts

ExcerptRelevanceReference
" We investigated for the first time whether class I histone deacetylase inhibitor valproic acid (VPA) can reverse cognitive deficits in a mouse model of sepsis-associated encephalopathy (SAE)."3.79Class I histone deacetylase inhibitor valproic acid reverses cognitive deficits in a mouse model of septic encephalopathy. ( Dong, L; Ji, M; Jia, M; Qiu, L; Wu, J; Yang, J; Zhang, G; Zhang, M, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wu, J1
Dong, L1
Zhang, M1
Jia, M1
Zhang, G1
Qiu, L1
Ji, M1
Yang, J1

Other Studies

1 other study available for staurosporine aglycone and Brain Disorders

ArticleYear
Class I histone deacetylase inhibitor valproic acid reverses cognitive deficits in a mouse model of septic encephalopathy.
    Neurochemical research, 2013, Volume: 38, Issue:11

    Topics: Animals; Brain Diseases; Brain-Derived Neurotrophic Factor; Carbazoles; Cecum; Cognition Disorders;

2013